Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Locatelli

Showing results (331-340 of 377) with videos related to

Pageof 38
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidismPiergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy TrialTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2012
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trialFrancesco Locatelli, Paolo Altieri, Simeone Andrulli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 21, 2014
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)Iain C Macdougall, Nicole Casadevall, Francesco Locatelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 23, 2023
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysisBeatriz Martín-Carro, Juan F Navarro-González, Alberto Ortiz, et al.
BMC Nephrology|July 13, 2016
Low-protein diets for chronic kidney disease patients: the Italian experienceVincenzo Bellizzi, Adamasco Cupisti, Francesco Locatelli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
NDT Plus|May 19, 2015
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Raymond Vanholder, Daniel Abramowicz, Jorge B Cannata-Andia, et al.
Pageof 38

Showing results (331-340 of 377) with videos related to

Sort By:
Pageof 38
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidismPiergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy TrialTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2012
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trialFrancesco Locatelli, Paolo Altieri, Simeone Andrulli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 21, 2014
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)Iain C Macdougall, Nicole Casadevall, Francesco Locatelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 23, 2023
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysisBeatriz Martín-Carro, Juan F Navarro-González, Alberto Ortiz, et al.
BMC Nephrology|July 13, 2016
Low-protein diets for chronic kidney disease patients: the Italian experienceVincenzo Bellizzi, Adamasco Cupisti, Francesco Locatelli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
NDT Plus|May 19, 2015
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Raymond Vanholder, Daniel Abramowicz, Jorge B Cannata-Andia, et al.
Pageof 38